Marinus Pharmaceuticals Inc (NASDAQ: MRNS) stock suffered a major decline of -14.1% on 11/9/23. The shares closed at $5.93. The stock has been strong relative to the market over the last nine months but has […]
Computer Programs and Systems In (NASDAQ: CPSI) stock closed at $11.67 on 11/9/23 after a major decline of -11.5%. The stock has declined -17.6% during the last week and has been extremely weak relative to […]
On 11/9/23, Enerflex Ltd (NYSE: EFXT) stock enjoyed a major increase of 10.4%, closing at $4.55. The stock has been weak relative to the market over the last nine months but has risen 8.6% during […]
For its first fiscal quarter (ending September 30), Tapestry Inc (NYSE: TPR) has reported a 5% increase in E.P.S. from $0.81 a year ago to $0.85 in the current quarter. Relative to the consensus estimate […]
Astronics Corp (NASDAQ: ATRO) stock closed at $14.33 on 11/9/23 after a major decline of -13.4%. The stock has been exceptionally strong relative to the market over the last nine months but has declined -6.2% […]
Eagle Pharmaceuticals Inc (NASDAQ: EGRX) stock closed at $9.54 on 11/9/23 after a major decline of -30.4%. The stock has been extremely weak relative to the market over the last nine months and has declined […]
Identiv Inc (NASDAQ: INVE) stock suffered a major decline of -16.3% on 11/8/23. The shares closed at $5.04. The stock has been exceptionally strong relative to the market over the last nine months but has […]
ViaSat Inc. (NASDAQ: VSAT) has reported a loss for its second fiscal quarter (ending September 30) of $-6.16 versus a loss $-0.93 for the same period a year ago. For the latest four quarters through […]
For its fourth fiscal quarter (ending September 30), The Walt Disney Co (NYSE: DIS) has reported a 56% increase in E.P.S. from $0.09 a year ago to $0.14 in the current quarter. However, this performance […]
B&G Foods Inc (NYSE: BGS) has reported E.P.S. of $-1.11 for its third fiscal quarter (ending September 30) versus $-0.83 for the same period a year ago. This result fell short of the consensus estimate […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research